Vasodilatatoren und positiv-inotrope Pharmaka

  • H. P. Schuster

Zusammenfassung

Zum Verständnis der Pharmakoptherapie bei Herzinsuffizienz sei an zwei hämodynamische Besonderheiten des insuffizienten linken Ventrikels erinnert:
  • Die Ventrikelfunktionskurve verläuft abnorm: sie ist abgeflacht, erreicht ihr Maximum bei höheren Füllungsdrücken und fällt bei weiterer Steigerung des Füllungsdruckes möglicherweise wieder ab.

  • Die Förderleistung des Herzens hängt in starkem Maße vom peripheren Gefäßwiderstand ab.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Bayley S, Valentine H, Bennett ED (1984) The haemodynamic responses to incremental doses of intravenous nitroglycerin in left ventricular failure. Intensive Care Med 10: 139–145PubMedCrossRefGoogle Scholar
  2. 2.
    Biddle TL, Benotti JR, Creager A et al. (1987) Comparison of intravenous milgrinone and dobutamine for congestive heart failure secondary to either ischemic or dilated cardiomyopathy. Am J Cardiol 59: 1345–1350PubMedCrossRefGoogle Scholar
  3. 3.
    Boldt J, Kling D, Schuhmann E et al. (1989) Hämodynamische Effekte des neuen Phosphodiesterasehemmers Enoximone bei kardiochirurgischen Patienten. Anaesthesist 38: 238–244PubMedGoogle Scholar
  4. 4.
    Chatterjee K (1973) Hemodynamic and metabolic responses to vasodilator therapy in acute myocardial infarction. Circulation 48: 1183PubMedCrossRefGoogle Scholar
  5. 5.
    Crexells C, Chatterjee K, Forrester JS et al. (1973) Optimal level of filling pressure in the left side of the heart in acute myocardial infarction. N Engl J Med 289: 1263–1266PubMedCrossRefGoogle Scholar
  6. 6.
    Cyran J, Kühnl C, Zähringer J et al. (1978) Die Änderung der Hämodynamik des Herzens unter dem kombinierten Einfluß von Nitroglyzerin und Dopamin bei hochgradiger Linksherzinsuffizienz. Z Kardiol 67: 759–765PubMedGoogle Scholar
  7. 7.
    Cyran J, Bolte HD (1981) Parenterale Kombinationstherapie mit Katecholaminen und Vasodilatantien bei koronarer Herzkrankheit. In: Bolte HD (Hrsg) Katecholamine und Vasodilatantien bei Herzinsuffizienz. Springer, Berlin Heidelberg New York, S 55–63CrossRefGoogle Scholar
  8. 8.
    Desjars P, Pinaud M, Bugnon D, Tasseau F (1989) Norepinephrine therapy has no deleterious renal effects in human septic shock. Crit Care Med 17: 426–429PubMedCrossRefGoogle Scholar
  9. 9.
    Fowler MB, Alderman EL, Oesterle SN et al. (1984) Dobutamine and dopamine after cardiac surgery: greater aufmentation of myocardial blood flow with dobutamine. Circulation 70: I-103-I-111Google Scholar
  10. 10.
    Franciosa JA, Dunkman WB, Wilen M. Silverstein SR (1983) „Optimal“ left ventricular filling pressure during nitroprusside infusion for congestive heart failure. Am J Med 74: 457–464PubMedCrossRefGoogle Scholar
  11. 11.
    Francis GS, Sharma B, Hodges M (1982) Comparative hemodynamic effects of dopamine and dobutamine in patients with acute cardiogenic circulatory collapse. Am Heart J 103: 995–1000PubMedCrossRefGoogle Scholar
  12. 12.
    Gage J, Rutman H, Lucido D (1986) Additive effects of dobutamine and amrinone on myocardial contractility and ventricular performance in patients with severe heart failure. Circulation 74: 367–371PubMedCrossRefGoogle Scholar
  13. 13.
    Goldstein RA, Passamani ER, Roberts R (1980) A comparison of digoxin and dobutamine in patients with acute infarction and cardiac failure. N Engl J Med 303: 846–850PubMedCrossRefGoogle Scholar
  14. 14.
    Heuer H, Frenking B, Müller US, Gülker H (1987) Wirkung von Amrinon bei akuter schwerer Herzinsuffizienz. Intensivmed 24: 133–137 31.Google Scholar
  15. 15.
    Hoffmann P, Schockenhoff (1985) Amrinon beim katecholaminrefraktären Herzversagen im septischen Schock. Anaesthesist 34: 663–669PubMedGoogle Scholar
  16. 16.
    Installé E, Gonzalez M, Jacquemart JL et al. (1987) Comparative effects on hemodynamics of enoximone (MDL 17,043), dobutamine and nitroprusside in severe congestive heart failure. Am J Cardiol 60: 46C - 52CPubMedCrossRefGoogle Scholar
  17. 17.
    Keung ECH, Siskind SJ, Sonneblick EH et al. (1981) Dobutamine therapy in acute myocardial infarction. J Amer med Ass 245: 144–146CrossRefGoogle Scholar
  18. 18.
    Konstam MA, Cohen SR, Weiland DS et al. (1986) Relative contribution of inotropic and vasodilator effects to amrinone-induced hemodynamic improvement in congestive heart failure. Am J Cardiol 57: 242–248PubMedCrossRefGoogle Scholar
  19. 19.
    Leier CV, Bambach D, Thompson MJ et al. (1981) Central and regional hemodynamic effects of intravenous isosorbide dinitrate, nitroglycerin and nitroprusside in patients with congestive heart failure. Am J Cardiol 48: 1115–1123PubMedCrossRefGoogle Scholar
  20. 20.
    Leier CV. Binkley PF, Carpenter J et al. (1988) Cardiovascular pharmacology of dopexamine in low output congestive heart failure. Am J Cardiol 62: 94–99PubMedCrossRefGoogle Scholar
  21. 21.
    Loeb HS, Bredakis J, Gunnar RMN: Superiority of dobutamine over dopamine for augmentation of cardiac output in patients with chronic low output cardiac failure. Circulation 65: 375–381Google Scholar
  22. 22.
    Mager G, Klocke RK, Kux A et al. (1990) Therapie des kardiogenen Schocks and der schwersten Herzinsuffizienz mit dem Phosphodiesterasehemmer Milrinon. Intensivmed 27Google Scholar
  23. 23.
    Martyn J, Wilson RS, Burke JF (1986) Right ventricular function and pulmonary hemodynamics during dopamine infusion in burned patients. Chest 89: 357–360PubMedCrossRefGoogle Scholar
  24. 24.
    Meadows D, Edwards JD, Wilkins RG, Nightingale P (1988) Reversal of intractable septic shock with norepinephrine therapy. Crit Care Med 16: 663–666PubMedCrossRefGoogle Scholar
  25. 25.
    Müller HS (1979) Myokardinfarkt–Kardiogener Schock. Intensivmed 16: 115–121Google Scholar
  26. 26.
    Nelson GLC, Silke B. Ahuja RC, Hussain M (1983) Haemodynamic advantages of isosorbide dinitrate over frusemide in acute heart-failure following myocardial infarction. Lancet 1: 730–733PubMedCrossRefGoogle Scholar
  27. 27.
    Nienaber CA, Spielmann RP, Aschenberg W et al. (1987) Comparison of the acute hemodynamic response to intravenous nisoldipine (Bay K 5552) and intravenous nifedipine for left ventricular dysfunction secondary to myocardial infarction. Am J Cardiol 60: 836–841PubMedCrossRefGoogle Scholar
  28. 28.
    Rennotte MT, Reynaert M, Clerbaux T et al. (1989) Effects of two inotropic drugs, dopamine and dobutamine, on pulmonary gas exchange in artificially ventilated patients. Intensive Care Med 15: 160–165PubMedCrossRefGoogle Scholar
  29. 29.
    Richard C, Ricome JL, Rimalho A et al. (1983) Combined hemodynamic effects of dopamine and dobutamine in cardiogenic shock. Circulation 67: 620–626PubMedCrossRefGoogle Scholar
  30. 30.
    Schuster HP (1985) Behandlung von Herzinsuffizienz and Schock. Verh Dtsch Ges Inn Med 91: 212–225PubMedGoogle Scholar
  31. 31.
    Svenson G, Strandberg LE, Lindvall B. Erhardt L (1988) Haemodynamic response to dopexamine hydrochloride in postinfarction heart failure: lack of tolerance after continuous infusion. Br Heart J 60: 489–496PubMedCrossRefGoogle Scholar
  32. 32.
    Vincent JL, Carlier E, Berr’e J et al. (1988) Am J Cardiol 62: 419–423PubMedCrossRefGoogle Scholar
  33. 33.
    Worthley LIG, Tyler P, Maron JL (1985) A comparison of dopamine, dobutamine and isoproterenol in the treatment of shock. Intensive Care Med 11: 13–19PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • H. P. Schuster

There are no affiliations available

Personalised recommendations